425 related articles for article (PubMed ID: 18190323)
1. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
Safdar A; Rolston KV
Clin Infect Dis; 2007 Dec; 45(12):1602-9. PubMed ID: 18190323
[TBL] [Abstract][Full Text] [Related]
2. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
Ansari SR; Hanna H; Hachem R; Jiang Y; Rolston K; Raad I
Cancer; 2007 Jun; 109(12):2615-22. PubMed ID: 17487860
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
5. Optimizing therapy for Stenotrophomonas maltophilia.
Muder RR
Semin Respir Crit Care Med; 2007 Dec; 28(6):672-7. PubMed ID: 18095231
[TBL] [Abstract][Full Text] [Related]
6. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
7. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of septic arthritis.
Aydemir C; Aktaş E; Eldeş N; Kutsal E; Demirel F; Ege A
Turk J Pediatr; 2008; 50(1):89-90. PubMed ID: 18365601
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteremia.
Krcmery V; Trupl J; Svetlansky I
Clin Infect Dis; 2001 Jun; 32(11):1656. PubMed ID: 11340542
[No Abstract] [Full Text] [Related]
9. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.
Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
Fihman V; Le Monnier A; Corvec S; Jaureguy F; Tankovic J; Jacquier H; Carbonnelle E; Bille E; Illiaquer M; Cattoir V; Zahar JR
J Infect; 2012 Apr; 64(4):391-8. PubMed ID: 22245400
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea.
Apisarnthanarak A; Fraser VJ; Dunne WM; Little JR; Hoppe-Bauer J; Mayfield JL; Polish LB
Clin Infect Dis; 2003 Oct; 37(8):1131-5. PubMed ID: 14523780
[TBL] [Abstract][Full Text] [Related]
12. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
13. Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols.
Pakyz AL; Farr BM
Epidemiol Infect; 2009 Dec; 137(12):1679-83. PubMed ID: 19874637
[TBL] [Abstract][Full Text] [Related]
14. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
15. [An update on the susceptibility of Stenotrophomonas maltophilia].
Sevillano D; Valdezate S; Gómez-Lus ML
Rev Esp Quimioter; 2001 Jun; 14(2):138-54. PubMed ID: 11704768
[No Abstract] [Full Text] [Related]
16. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
Abbott IJ; Slavin MA; Turnidge JD; Thursky KA; Worth LJ
Expert Rev Anti Infect Ther; 2011 Apr; 9(4):471-88. PubMed ID: 21504403
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.
Mutlu M; Yılmaz G; Aslan Y; Bayramoğlu G
J Microbiol Immunol Infect; 2011 Dec; 44(6):467-72. PubMed ID: 21606009
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.
Senol E
J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709
[TBL] [Abstract][Full Text] [Related]
19. A meningitis case due to Stenotrophomonas maltophilia and review of the literature.
Yemisen M; Mete B; Tunali Y; Yentur E; Ozturk R
Int J Infect Dis; 2008 Nov; 12(6):e125-7. PubMed ID: 18579427
[TBL] [Abstract][Full Text] [Related]
20. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
